On September 26, 2024 at 5:12 PM EDT, Aion Therapeutic Inc. provided an update on the management cease trade order issued on August 29, 2024, by its principal regulator, the British Columbia Securities Commission (BCSC), under National Policy 12-203 Management Cease Trade Orders (NP 12-203). The company announced on August 14, 2024, that it would be unable to file its annual audited consolidated financial statements for the financial year ended April 30, 2024, by the filing deadline of August 28, 2024. The BCSC has granted the company an extension until October 28, 2024, to complete its 2024 Financial Disclosure.
The delay in filing is due to the complexities associated with the acquisition of Toppen Health, Inc. on December 15, 2023. Aion Therapeutic is working diligently to finalize the financial disclosure and expects to meet the extended deadline.
There have been no material changes to the information provided in the Default Announcement. The company confirms its commitment to comply with the Alternative Information Guidelines outlined in NP 12-203 and will continue to issue bi-weekly default status reports until the financial disclosure is completed. As of now, there is no information regarding any anticipated specified default, insolvency proceedings, or undisclosed material information concerning the company.
Aion Therapeutic Inc. is a forward-thinking health and wellness company with a diverse portfolio of intellectual property. The company, along with its subsidiary Toppen, specializes in providing innovative water filtration solutions that are affordable and sustainable.
This press release contains forward-looking information subject to risks and uncertainties. Readers are advised not to place undue reliance on this information as it may not prove to be correct. The securities of the company have not been registered under the United States Securities Act of 1933. This press release is for informational purposes only and does not constitute an offer to sell securities.
The Canadian Securities Exchange has not approved the contents of this press release. For the source version of this release, please visit [source link].
